HPV-linked throat cancer risk climbs over time, study suggests

A new study tracking HPV16 antibodies found that oropharyngeal cancer risk associated with the virus increases as years pass, challenging assumptions about infection timing. The finding could reshape screening strategies and treatment planning for the fastest-growing cancer type in developed nations.

Originaltitel: HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study